Members Sign In
Members Sign InAll | Clinical Notices | General Notices | Vacancies
Kia ora koutou,
We are delighted to see that Associate Professor Martin de Bock and Professor Ben Wheeler, on behalf of a much wider collaborative Aotearoa wide diabetes research team, have been awarded the Health Research Council Beaven Medal. This is for health research leadership that has led to direct translational improvements in care for all people living with diabetes in Aotearoa New Zealand and beyond.
Specific contributions noted included their roles in: clinical trial research and pathway to regulatory approval for numerous advanced diabetes technologies; significant role in national and international guidelines and policy; cross sectional partnerships across industry as well as directly with the diabetes community; and their important role, as a small part in a much larger community effort, in advocacy for improved models of care, equity, and diabetes technology access for all people living with diabetes. We will continue to see the impact of this in our clinical practice and the health and wellbeing of people who live with type 1 diabetes in years to come.
This is an outstanding award and particularly significant for the NZSSD community as Sir Donald Ward Beaven was a lead medical researcher in Diabetes Care and was a previous President of NZSSD.
Martin and Ben want to specifically acknowledge that this was awarded on behalf of all the work that everyone in the diabetes community has done to improve care to all New Zealanders living with diabetes.
I am sure you will join me in congratulating Martin and Ben and celebrating this achievement.
Ngā mihi nui,
Jo
Dr Jo McClintock (she/her)
Consultant Clinical Psychologist | Kaimatai Hauora Hinengaro
President New Zealand Society for the Study of Diabetes
Welcome to Issue 195 of Diabetes and Obesity Research Review.
In this issue, we have quite a bit of GLP-1 receptor agonist research, including a trial of once-monthly subcutaneous injections of maridebart cafraglutide, a long-acting peptide-antibody conjugate combining GLP-1 receptor agonism with GIP receptor antagonism, in patients with obesity, as well as a phase 3 trial reporting significant reductions in HbA1c level with the small-molecule, nonpeptide GLP-1 receptor agonist orforglipron.
As usual we have attached the PDF, and you can also view the issue online.
Some of the other highlights include:
We hope you enjoy the papers selected for this issue and find them beneficial to you and your patients. Your feedback and suggestions are always welcome, please continue to send them in.
Kind regards,
Professor Jeremy Krebs
jeremykrebs@researchreview.co.nz
Kia ora koutou
We are happy to provide further details about the 49th NZSSD Annual Scientific Meeting to be held in-person in Napier from Wednesday 6 - Friday 8 May 2026 at Napier Conference and Events Centre. This will include the Annual General Meeting for NZSSD. Also, a reminder that in 2026 we will be celebrating 50 years as a society.
Additionally there will be SIG study sessions on Tuesday 5 May hosted by Diabetic Foot, Dietitians and Technology groups. The registrar training day will also be held on Tuesday 5 May.
We are also very happy to announce that we have our first invited keynote speaker confirmed. Professor Ketan Dhatariya will be joining us from Norfolk & Norwich University Hospital NHS Trust in the United Kingdom. Some members of the society heard him present at the recent Australian meeting and were very keen to see if we could entice him to Aotearoa. His bio will be up on the conference website soon.
Expect to see more details over the coming months with the programme updated as we confirm more speakers and of course most importantly the theme for the ASM dinner!
As in previous years, registrations and calls for abstract submissions will open in early December via the Conference website. The Executive will also be taking nominations for the Bob Smith lecture then and so keep an eye out for that invitation as these will go directly to them for selection.
Nga mihi,
Sonya Fraser and Lisa Hoyle
ASM co-convenors
The HumaPen Savvio® (insulin delivery device) ordering process is changing. Starting October 1, 2025, hospitals will no longer need to order HumaPen Savvio® units through Eli Lilly Customer Service.
Instead, Lilly is introducing an allocation program. Hospitals will be able to receive free-of-charge HumaPen Savvio® units every three months for their patients.
Click the link to register for the program.
Please see the attached email for more information.
Click HERE for more information
Details of the 2026 Diabetes New Zealand Research Foundation Fellowship, eligibility criteria, scope, funding and guidelines for applicants are provided on their website. Click HERE
The research must be conducted in New Zealand, be specifically related to diabetes and aligned to the DNZRF's mission statements
If you have any questions about the fellowship, your eligibility to apply, funding or assessment process please email admin@dnzrf.org.nz.
Welcome to Issue 194 of Diabetes and Obesity Research Review.
In this issue, we cross the ditch for a report on the management of diabetes among Aboriginal and Torres Strait Islander Australians, with some findings that are relevant for us in Aotearoa.
we have attached the PDF, and you can also view the issue online.
Some of the other highlights include:
We hope you enjoy the papers selected for this issue and find them beneficial to you and your patients. Your feedback and suggestions are always welcome, please continue to send them in.
Kind regards,
Professor Jeremy Krebs
jeremykrebs@researchreview.co.nz
Kia ora koutou,
Diabetes-specific nutrition formulations (DSNFs) are becoming an important part of diabetes care in Aotearoa New Zealand with the introduction of new medicines. They are available in Aotearoa New Zealand either Pharmac subsidised on prescription or self-funded to support people with type 1 or type 2 diabetes experiencing weight loss and malnutrition requiring nutritional support, or unable to maintain adequate nutritional intake in women with diabetes in pregnancy. We are also aware that new DSNF products are entering the market imminently.
These specialised products are designed to assist with glycaemic control and provide additional nutrition, particularly for individuals with complex health needs and a poor appetite, or those requiring enteral nutrition.
Ideally the use of these formulations should be guided by a qualified dietitian following a comprehensive nutrition assessment. Dietetic involvement ensures there is:
NZSSD dietitians as well as members from other disciplines plan to work on a Consensus Statement for the use of these products in our local Aotearoa context over the coming months. Please contact us if you have any questions or would be interested in contributing to this important piece of work.
Ngā mihi,
Dr Jo McClintock (she/her)
President New Zealand Society for the Study of Diabetes
Click HERE for more information and to register
The information for this is available directly on the website here
Additional promotional materials can be downloaded from the IVW Website.
On behalf of the Psychology - Hinengaro Special Interest Group I am both pleased and proud to advise the Diabetes, Eating Behaviours, and Body Satisfaction Guidance is now live on the NZSSD website - CLICK HERE. Some of you would have heard the "whistle stop tour" at the recent ASM.
This guidance addresses an unmet need through the development of screening, assessment, and treatment recommendations for tāngata whaiora who live with diabetes and who face challenges with body satisfaction and eating behaviours, regardless of the type of diabetes they have. We have also provided strategies for kaimahi positionality and engagement.
This guidance was developed by working and consultation rōpū and the approach taken was embedded in Te Tiriti o Waitangi principles as well as ensuring the voice of lived experience was heard.
This guidance is written for kaimahi (health professionals) working with tāngata whaiora who live with any type of diabetes.
He kokonga whare e kitea, he kokonga ngākau e kore e kitea
A corner of a house may be seen and examined; not so the corners of the heart
We hope you find this useful and we welcome your thoughts and feedback.
Kia ora koutou,
Dr Jo McClintock (she/her)
Consultant Clinical Psychologist | Kaimātai Hauora Hinengaro
President New Zealand Society for the Study of Diabetes
For those wishing to view they are titled "Proceedings of the New Zealand Society for the Study of Diabetes Annual Scientific Meeting 14-16 May 2025, Kirikiriroa, Hamilton" and are found on pages 77 to 90 of the The New Zealand Medical Journal.
Thank you for all the incredible mahi and contributions to improving the care and outcomes for those living with diabetes in Aotearoa and for your support of our ASM.
ECR Connect is a dedicated online weekend workshop targeted at early career investigators to support career, research and professional development among peers. ECR Connect is a joint initiative led by Australian and New Zealand Bone Mineral Society Early Career Investigator Committee (ANZBMS ECIC) in collaboration with the Endocrine Society of Australia (ESA) and Australian Diabetes Society (ADS).
Please see full details on the attached flyer.
Warning: Fake Videos Targeting People with Type 2 Diabetes
The New Zealand Society for the Study of Diabetes (NZSSD) is warning people with type 2 diabetes to be cautious about health advice on social media, especially videos that appear to be from New Zealand doctors.
Please download the PDF for more information.
Click HERE for the latest issue
Welcome to Issue 189 of Diabetes and Obesity Research Review.
With the flu season upon us, this issue includes research reminding us of the importance of ensuring our patients with diabetes get vaccinated!
As usual we have attached the PDF, and you can also view the issue online.
Some of the other highlights include:
We hope you enjoy the papers selected for this issue and find them beneficial to you and your patients. Your feedback and suggestions are always welcome, please continue to send them in.
Kind regards,
Professor Jeremy Krebs
The Diabetes and Related Conditions Prescribing Meeting is an opportunity to receive updates on contemporary clinical management and prescribing in diabetes care, and to connect and network with your peers involved or with an interest in diabetes care. The meeting is open to registered nurses and pharmacists with prescribing current authority and nurse practitioners.
The meeting will be held at the Novotel Hotel, Auckland Airport on Tuesday 5th and Wednesday 6th August, 2025.
Here is the link to the meeting information and registration site:
https://www.eventleaf.com/e/DiabetesPrescribingMeeting2025